Design and Characterization of a Recombinant Brucella abortus RB51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response

(2022) Design and Characterization of a Recombinant Brucella abortus RB51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response. VACCINES. ISSN 2076-393X J9 - VACCINES-BASEL

Full text not available from this repository.

Abstract

Brucella abortus vaccines help control bovine brucellosis. The RB51 strain is a live attenuated vaccine with low side effects compared with other live attenuated brucellosis vaccines, but it provides insufficient protective efficacy. Cell-mediated immune responses are critical in resistance against intracellular bacterial infections. Therefore, we hypothesized that the listeriolysin O (LLO) expression of Listeria monocytogenes, BAX, and SMAC apoptotic proteins in strain RB51 could enhance vaccine efficacy and safety. B. abortus RB51 was transformed separately with two broad-host-range plasmids (pbbrlori-LLO and pBlu-mLLO-BAX-SMAC) constructed from our recent work. pbbrlori-LLO contains LLO, and pBlu-mLLO-BAX-SMAC contains the mutant LLO and BAX-SMAC fusion gene. The murine macrophage-like cell line J774A.1 was infected with the RB51 recombinant strain containing pBlu-mLLO-BAX-SMAC, RB51 recombinant strain containing LLO, and RB51 strain. The bacterial cytotoxicity and survival and apoptosis of host cells contaminated with our two strain types-RB51 recombinants or the parental RB51-were assessed. Strain RB51 expressing mLLO and BAX-SMAC was tested in BALB/c mice and a cell line for enhanced modulation of IFN-y production. LDH analysis showed that the RB51-mLLO-BAX-SMAC and RB51-LLO strains expressed higher cytotoxicity in J774A.1 cells than RB51. In addition, RB51 recombinants had lower macrophage survival rates and caused higher levels of apoptosis and necrosis. Mice vaccinated with the RB51 recombinant containing mLLO-BAX-SMAC showed an enhanced Th1 immune response. This enhanced immune response is primarily due to bacterial endosome escape and bacterial antigens, leading to improved apoptosis and cross-priming. This potentially enhanced TCD8+- and T cell-mediated immunity leads to the increased safety and potency of the RB51 recombinant (RB51 mLLO-BAX-SMAC) as a vaccine candidate against B. abortus.

Item Type: Article
Keywords: Brucella abortus RB51 strain listeriolysin O (LLO) BAX and SMAC apoptotic proteins Th1 immune response STRAIN RB51 EXPRESSION PROTECTION CHALLENGE PROTEIN LISTERIOLYSIN OPTIMIZATION TRAFFICKING INDUCTION EFFICACY
Journal or Publication Title: VACCINES
Journal Index: ISI
Volume: 10
Number: 3
Identification Number: https://doi.org/10.3390/vaccines10030388
ISSN: 2076-393X J9 - VACCINES-BASEL
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/16028

Actions (login required)

View Item View Item